Heron Therapeutics (FRA:AXD2) Tax Rate %: 0.00% (As of Mar. 2026)

What is Heron Therapeutics Tax Rate %?

Heron Therapeutics FRA:AXD2 -1.66% 49 Tax Rate % is 0.00% as of Mar. 2026. GuruFocus rates FRA:AXD2 with a GF Score™ of 49/100 and a GF Value™ of €1.29 (Possible Value Trap). The stock has 4 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Heron Therapeutics's Tax Expense for the three months ended in Mar. 2026 was €0.0 Mil. Heron Therapeutics's Pre-Tax Income for the three months ended in Mar. 2026 was €-7.0 Mil. Therefore, Heron Therapeutics's Tax Rate % for the quarter that ended in Mar. 2026 was 0.00%.

Heron Therapeutics Tax Rate % Related Terms

Heron Therapeutics Tax Rate % Historical Data

* Premium members only.

The historical data trend for Heron Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heron Therapeutics Tax Rate % Chart

Heron Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Tax Rate %

Get a 7-Day Free Trial

0.00

Heron Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Tax Rate %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

49GF Score

Heron Therapeutics Inc FRA:AXD2

Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Heron Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Heron Therapeutics's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2025 )	/	Pre-Tax Income (A: Dec. 2025 )
	=	0	/	-17.247
	=	0.00 %

Heron Therapeutics's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %	=	Tax Expense (Q: Mar. 2026 )	/	Pre-Tax Income (Q: Mar. 2026 )
	=	0	/	-7.016
	=	0.00 %

Frequently Asked Questions Learn more about Tax Rate % →

What does a Tax Rate % of 0.00% mean?

Heron Therapeutics (FRA:AXD2) has a Tax Rate % of 0.00% as of Mar. 2026.

Is Heron Therapeutics' Tax Rate % too high?

Heron Therapeutics' current Tax Rate % is 0.00%. Overall, Heron Therapeutics has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Heron Therapeutics' Tax Rate % compare to ENTX and OKYO?

Heron Therapeutics' Tax Rate % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Tax Rate % for a Biotechnology company?

A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Tax Rate % mean?

A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Heron Therapeutics's current Tax Rate % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Heron Therapeutics stock overvalued right now?

Based on GuruFocus' analysis, Heron Therapeutics (FRA:AXD2) is currently considered Possible Value Trap. The stock's GF Value™ is €1.29, compared to a current price of €0.37 — trading 71.5% below its estimated fair value. The current Tax Rate % is 0.00%. Heron Therapeutics' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Tax Rate % calculated?

Tax Rate % is calculated from a company's financial statements. For Heron Therapeutics (FRA:AXD2), the current Tax Rate % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Heron Therapeutics (FRA:AXD2) Overvalued in 2026?

Based on GuruFocus' analysis, Heron Therapeutics stock appears to be undervalued. The current stock price of €0.37 is trading 71.5% below its estimated GF Value™ of €1.29. GuruFocus considers Heron Therapeutics to be Possible Value Trap.

Key valuation signals for FRA:AXD2:

Tax Rate %: 0.00%
GF Value™: €1.29 vs. price of €0.37 (71.5% below fair value)
GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the FRA:AXD2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Heron Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies ENTX OKYO EDSA ACET RANI IBIO RNTX GOSS OSTX ELTX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges HRTX:USA 0J4V:UK AXD2:Germany

Address 100 Regency Forect Drive, Suite 300, Cary, NC, USA, 27518

Website https://www.herontx.com

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

49GF Score

Get the complete analysis for FRA:AXD2

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.37

Price

€1.29

GF Value

View FRA:AXD2 Analysis

See Tax Rate % data for all stocks →